Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates

Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates

US Patent 9828428 · Granted Nov 28, 2017

Estimated economic value: $611,566,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDCP1 antibodies and antibody drug conjugates2025
Anti-CD8 antibodies and uses thereof2024
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging2024
Radiolabeled MET binding proteins for immuno-PET imaging and methods of use ther2024
Single domain binding molecule2023
Humanized antibodies2023
Anti-CD8 antibodies and uses thereof2022
Radiolabeled anti-LAG3 antibodies for immuno-PET imaging2022
Antibodies specific for CD3 and uses thereof2022
Antibodies specific for CD3 and uses thereof2022
Engineered antibody constant regions for site-specific conjugation and methods a2021
Pyrimidine compound, chloride salt thereof, and manufacturing and application of2021